Protara Therapeutics (TARA) Stock Highlights

5.39 | +4.05%

2024-12-21 07:13:26

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Statistics

Range Today

5.01 5.41

Volume Today 1M

Range 1 Year

1.6 10.48

Volume 1 Year 182.93M

Range 3 Year

1.04 10.48

Volume 3 Year 201.28M

Range 10 Year

1.04 800

Volume 10 Year 259.77M

Highlights

Market Capitalization 52.4M (small)

Floating Shares 15.17M

Current Price 5.39

Price To Earnings -0.84

Price To Book 0.57

Earnings Per Share -3.01

Payout Ratio 0%

Performance

Latest +4.05%

1 Month +134.35%

3 Months +173.6%

6 Months +136.4%

1 Year +185.19%

3 Years -17.46%

5 Years -55.82%

10 Years -98.66%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.